1Livermore DM. Determinants of the activity of β - lactamase inhibitor combinations[J]. J Antimicrob Chemother, 1993, 31 (Supp A): 9.
2Payne DJ, Cramp R, Winstanley DJ, et al. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important B - lactamases [ J ]. Antimicrob Agents Chemother, 1994, 38: 767.
3Kuck NA, Jacubos NV, Petersen PJ, et al. Comparative in vitro and in vivo activities of piperacillin combined with the B- lactamase inhibitors tazobactam, clavulanic acid, and sulbactam[J]. Antimicrob Agents Chemother;1989, 33:1 964.
4Stewart M, Taylor EW, Lindsay G. Infection after colorectal surgery: a randomized trial of prophylaxis with piperacillin versus sulbactam /piperacillin[J]. J Hosp Infect, 1995 , 29(2): 135 - 142.
5Manncke K, Springsklee M, Heizmann WR, et al. Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections[J]. Med Clin, 1991 ,86(9): 454 - 460.
